Natarajan Sethuraman, Chief Scientific Officer: Entrada Therapeutics TRDA Sell · Filed 23/04/19

Trade details

Type: Insider sale
Amount: $71,298
Shares · price: 3,961 sh · $18.00 a share
Held after: 171,325 sh
Stock: Entrada Therapeutics TRDA
Person: Natarajan SethuramanChief Scientific Officer
Trade date: 23/04/17
Filed: 23/04/19
Days to filing: 2 days

Sold 2.3% of holdings

Share of holding sold: 2.3%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/18~23/05/17

Natarajan Sethuraman's recent trades

Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$398.7K
25,907 sh
$398.7K
Filed 05/04
Traded 05/04
Natarajan SethuramanPresident, Research & Develop
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$375.7K
25,907 sh
$375.7K
Filed 05/04
Traded 05/04
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$235.8K
11,703 sh
$235.8K
Filed 24/12/03
Traded 24/12/03
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$82.8K
4,088 sh
$82.8K
Filed 24/12/03
Traded 24/12/02
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$2,000
100 sh
$2,000
Filed 24/12/03
Traded 24/11/29

Natarajan Sethuraman, Chief Officer — sold $71.3K of Entrada Therapeutics TRDA · 2.3% of holdings · 10b5-1 plan | Whalegun